Press Release
Category Added in a WPeMatico Campaign
-
BougeRV Introduces the T1 Portable Camping Light: Built for the Wild, Powered for 12 Nights
An all-in-one telescopic lighting solution delivering powerful, glare-free illumination for camping, overlanding, and outdoor living. HOUSTON, Feb. 5, 2026 /PRNewswire/…
Read More » -
Atlantic Street Capital Announces Sale of GAT Airline Ground Support to PrimeFlight Aviation Services
NEW YORK, Feb. 5, 2026 /PRNewswire/ — Atlantic Street Capital (“Atlantic Street” or “ASC”), a private equity firm that invests…
Read More » -
U.S. Ski & Snowboard and Google Announce Collaboration to Build an AI-Based Athlete Performance Tool
Industry-first video-analysis tool turns smartphones into high-precision motion capture sensors for Team USA skiers and snowboarders PARK CITY, Utah and…
Read More » -
All Interested Parties Invited to ASTM Organizational Meeting on Standards Development for Artificial Intelligence in Manufacturing Systems
WASHINGTON, Feb. 5, 2026 /PRNewswire/ — ASTM International will hold an organizational meeting on March 4–5, 2026, to explore the potential…
Read More » -
Call for Global Entries: Globee® Awards for Achievement to Recognize Excellence in Operations, Growth, Innovation, and Community Impact
Open to organizations of all sizes and industries worldwide, including government agencies and public sector departments. SAN FRANCISCO, Feb. 5,…
Read More » -
Pearl Meyer Continues Expanding Leadership Advisory Practice Through Acquisition of Ampersand Leadership Group and New Senior Lateral Hires, Including David T. Clary
Recent hires grow Leadership Advisory practice by 60% and bolster offerings to private equity sponsors and PE-backed enterprises. BOSTON, Feb.…
Read More » -
Jinx Expands to Cat Food, Partners with Tinx to Celebrate Cat Ownership as the Ultimate Dating Green Flag
As Valentine’s Day Approaches, Jinx and Tinx Team Up to Demonstrate Why Cat People Make Better Partners NEW YORK, Feb. 5,…
Read More » -
K36 Therapeutics Completes Dosing of First Cohort in Phase 1 Clinical Trial of KTX-2001 in Prostate Cancer, Announces New CMO
KTX-2001 being evaluated both as a monotherapy and in combination with darolutamide in metastatic castration-resistant prostate cancer (mCRPC) Shinta Cheng,…
Read More »
